Purchase Order W81K0224P0059
Award Date
10/1/24
Potential Completion Date
9/30/29
Potential Value
$744K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Roche Diagnostics Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation for the purchase of consumable laboratory test and quantification materials. The total ceiling value of the contract is $463,109.60, with a performance period through August 30, 2024. The contract does not have a set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
This contract is for the purchase of consumable lab test and quantification material by the Defense Health Agency, a defense agency. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical products. The contract has a firm fixed price, ceiling value of $463,109.60, and a period of performance ending on September 23, 2025. No set-aside designation was used. Roche Diagnostics holds multiple significant...
This is a firm fixed-price BPA call order awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for reagents and peripheral supplies for the pathology department. The contract, worth $99,999.80, has an ultimate completion date of September 30, 2019. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. This award is not set aside and is...
This is a $89,826.20 firm fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation for benchmark ultra service and maintenance in accordance with the attached performance work statement and pricing schedule. The contract has a period of performance through September 30, 2028 and was awarded on October 1, 2023. This award is not a set-aside contract. Roche Diagnostics is a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
This contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of REAGENTS AND SUPPLIES, with a Ceiling Value of $98,494.08. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing type, and the ultimate completion date is September 9, 2020. This award is associated with a larger...
This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, medical laboratory instruments, and associated products and services. The contract ceiling value is $24,910.00 and the ultimate completion date is September 30, 2025. The contract is for the delivery of COBAS assembly equipment and related services. Roche Diagnostics is an...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 22, a civilian agency within the Department of Veterans Affairs, to Roche Diagnostics Corporation for the supply of reagents. The contract has a ceiling value of $1,297,713.57 and a period of performance ending on August 10, 2023. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The...
This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, with a ceiling value of $302,000.00, is a Blanket Purchase Agreement (BPA) Call placed by the Defense Health Agency (DHA) for the procurement of REAGENTS AND CONSUMABLES. This BPA is part of a larger Indefinite Delivery Contract vehicle held by Roche Diagnostics to provide chemistry reagents...
This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and medical products. The contract, worth $23,680.50, is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) for COBAS assays. The contract has a firm fixed price and an ultimate completion date of September 30, 2025. No set-aside designation was used for this award. Roche Diagnostics Corporation holds multiple significant...